Table 1B.

Selected baseline medications and health care utilization after 1:1 PS matching. Values are % for binary variables and mean ± SD for continuous variables.

CharacteristicsMedicare, n = 6102MarketScan, n = 6934
ABATNFiABATNFi
Medications
  Glucocorticoids
    Oral glucocorticoids, ≤ 30 d34.632.920.522.0
    Oral glucocorticoids, ≤ 1 yr73.371.950.053.5
    Cumulative dose*, ≤ 1 yr1189.1 ± 1370.11166.7 ± 1470.7968.5 ± 3554.7928.8 ± 2932.4
  DMARD
    Methotrexate54.161.636.247.7
    Hydroxychloroquine28.524.021.520.4
    Leflunomide20.016.313.810.9
    Other nonbiologics19.016.012.712.0
    No. unique nonbiologic DMARD1.2 ± 0.81.2 ± 0.80.8 ± 0.90.9 ± 0.9
Cardiovascular drugs
  Beta blockers38.537.916.817.1
  Calcium channel blockers28.629.312.412.6
  ACEI/ARB49.850.523.723.8
  Nitrates8.68.42.62.4
  Statins44.245.819.419.3
  Nonstatin lipid lowering drugs9.08.95.86.1
  Antiplatelets11.111.43.84.1
  Anticoagulants12.712.55.55.7
  Anti-arrhythmics3.22.70.91.0
  Loop diuretics24.324.89.19.6
  Thiazide diuretics29.830.316.015.5
  Other diuretics9.610.15.65.7
Analgesics
  NSAID38.337.631.632.0
  COXIB10.710.78.17.6
  Opioids, ≤ 30 d34.634.120.519.2
Others
  Insulin10.09.75.35.6
  DPP4 inhibitors2.42.81.41.6
  Benzodiazepines6.46.716.817.3
  Bisphosphonates23.122.99.910.3
  PPI46.446.726.326.0
  No. unique generics14.8 ± 6.814.8 ± 6.99.9 ± 9.19.9 ± 8.1
  • * Prednisone equivalent dose in milligrams. ABA: abatacept; ACEI: angiotensin converting enzyme inhibitor; ARB: angiotensin receptor blocker; COPD: chronic obstructive pulmonary disease; COXIB: cyclooxygenase 2 inhibitors; CRP: C-reactive protein; DMARD: disease-modifying antirheumatic drugs; DPP4: dipeptidyl peptidase-4; ED: emergency department; ESR: erythrocyte sedimentation rate; HbA1C: hemoglobin A1C; NSAID: nonsteroidal anti-inflammatory drug; PPI: proton pump inhibitor; PS: propensity score; TIA: transient ischemic attack; VTE: venous thromboembolism; TNFi: tumor necrosis factor inhibitors.